You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LGND Exercise Disclosure
Espinoza Octavio · SEC Form 4 · Filed Aug 14, 2026
Exercise
Calculated transaction value
$0
Espinoza Octavio Chief Financial Officer
LGND
Transaction date
Aug 12, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed 2 days later
LGND daily price context
Close on/before transaction
$293.27
Aug 12, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-Qualified Stock Option (right to buy) on Common Stock
- Quantity / price
- 16,179 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0002001011-26-000115
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$11.04M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ligand Pharmaceuticals Inc LGND | Exercise | Aug 12, 2026 | $0 |
| Ligand Pharmaceuticals Inc LGND | Exercise | Aug 12, 2026 | $0 |
| Ligand Pharmaceuticals Inc LGND | Exercise | Aug 12, 2026 | $410.32K |
| Ligand Pharmaceuticals Inc LGND | Exercise | Aug 12, 2026 | $0 |
| Ligand Pharmaceuticals Inc LGND | Exercise | Aug 12, 2026 | $0 |
| Ligand Pharmaceuticals Inc LGND | Exercise | Aug 12, 2026 | $854.9K |
| Ligand Pharmaceuticals Inc LGND | Exercise | Aug 12, 2026 | $145.26K |
| Ligand Pharmaceuticals Inc LGND | Exercise | Aug 12, 2026 | $159.95K |
| Ligand Pharmaceuticals Inc LGND | Exercise | Aug 12, 2026 | $230.14K |
| Ligand Pharmaceuticals Inc LGND | Sale | Aug 12, 2026 | $9.24M |
| Ligand Pharmaceuticals Inc LGND Current | Exercise | Aug 12, 2026 | $0 |